New born pulse oximetry screening: A global perspective.
Critical congenital heart defects
Detection
Neonatal sepsis
Newborn infant
Pulse oximetry
Screening
Journal
Early human development
ISSN: 1872-6232
Titre abrégé: Early Hum Dev
Pays: Ireland
ID NLM: 7708381
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
pubmed:
23
9
2021
medline:
5
4
2022
entrez:
22
9
2021
Statut:
ppublish
Résumé
The possibility of pulse oximetry screening (POS) for congenital heart defects was first described over 20 years ago. Since then, an accumulation of research evidence and clinical practice experience has established POS as an important test to detect critical congenital heart defects (CCHDs). POS meets the criteria for universal screening and professional bodies around the globe have recommended universal POS. Many countries have already adopted POS while several others are working towards its implementation. In low and low-middle-income countries (LLMIC), POS has the additional potential for reducing morbidity and mortality from neonatal sepsis. This review summarises the evidence for POS and looks at current global uptake and different approaches to the implementation of POS.
Identifiants
pubmed: 34548207
pii: S0378-3782(21)00156-0
doi: 10.1016/j.earlhumdev.2021.105457
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
105457Informations de copyright
Copyright © 2021 Elsevier B.V. All rights reserved.